Cargando…
mTOR inhibitors effects on regulatory T cells and on dendritic cells
The mammalian target of rapamycin (mTOR), a cytoplasmic serine/threonine kinase, represents a key biologic “switch” modulating cell metabolisms in response to environmental signals and is now recognized as a central regulator of the immune system. There is an increasing body of evidence supporting t...
Autores principales: | Stallone, Giovanni, Infante, Barbara, Di Lorenzo, Adelaide, Rascio, Federica, Zaza, Gianluigi, Grandaliano, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886438/ https://www.ncbi.nlm.nih.gov/pubmed/27245075 http://dx.doi.org/10.1186/s12967-016-0916-7 |
Ejemplares similares
-
mTOR and Aging: An Old Fashioned Dress
por: Stallone, Giovanni, et al.
Publicado: (2019) -
mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis
por: Granata, Simona, et al.
Publicado: (2021) -
mTOR-inhibitors and post-transplant diabetes mellitus: a link still debated in kidney transplantation
por: Granata, Simona, et al.
Publicado: (2023) -
The Role of Natural Killer Cells in the Immune Response in Kidney Transplantation
por: Pontrelli, Paola, et al.
Publicado: (2020) -
On-line hemodiafiltration modulates atherosclerosis signaling in peripheral lymphomonocytes of hemodialysis patients
por: Simone, Simona, et al.
Publicado: (2021)